SCHEMBL254920

SCHEMBL254920

CC1CCCC(C(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13745995 1.00
SCHEMBL13851911 1.00
SCHEMBL25740979 1.00
SCHEMBL19886827 1.00
SCHEMBL13746718 1.00
SCHEMBL15978040 1.00
SCHEMBL24286866 0.93
SCHEMBL13856990 0.85
SCHEMBL15978041 0.84 L3MBTL1 (0.32)
SCHEMBL8791023 0.84 L3MBTL1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329463-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2024-02-28 EP disclosed
EP-4001287-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2024-01-17 EP disclosed
WO-2023239727-A1 LATS INHIBITORS AND USES THEREOF THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2023-12-14 WO disclosed
US-11839141-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-12-05 US disclosed
EP-3922728-B1 METHOD FOR PRODUCING (1R,3R)-3-(TRIFLUOROMETHYL)CYCLOHEXAN-1-OL AND INTERMEDIATE THEREOF API CORP (JP) 2023-11-29 EP disclosed
EP-3858945-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-11-29 EP disclosed
US-11827651-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-28 US disclosed
US-11820783-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-21 US disclosed
WO-2023209336-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2023-11-02 WO disclosed
EP-4219515-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2023-08-02 EP disclosed
US-7435829-B2 Pyrazolyl-substituted heterocycles and their use as phytosanitary products BAYER CROPSCIENCE AG (DE) 2008-10-14 US disclosed
EP-1947515-A2 Electrophotographic photosensitive member, and electrophotgraphic apparatus and process cartridge which make use of the same Canon Kabushiki Kaisha (JP) 2008-07-23 EP disclosed
US-20070203101-A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products FISCHER REINER 2007-08-30 US disclosed
US-20070203101-A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products FISCHER REINER 2007-08-30 US disclosed
US-20070179162-A1 Triazolopyrimdines BAYER CROPSCIENCE AG (DE) 2007-08-02 US disclosed
US-7230116-B2 Pyrazolyl-substituted heterocycles and their use as phytosanitary products BAYER CROPSCIENCE, AG (DE) 2007-06-12 US disclosed
WO-2007025586-A1 1-CYCLOALKYL-5-IODOTETRAZOLES LANXESS DEUTSCHLAND GMBH (DE) 2007-03-08 WO disclosed
US-6040449-A USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT BANYU PHARMACEUTICAL CO LTD (JP) 2000-03-21 US disclosed
US-5948792-A POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-09-07 US disclosed
EP-0930298-A1 FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-21 EP disclosed